Recent research focusing on Retatrutide at a dosage of 40mg is shedding new light on its potential effects. Early findings suggest that this higher dosage may amplify the drug's ability to manage blood levels, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate the long-